The burgeoning popularity of tirzepatide , initially for diabetes , is creating significant buzz within the UK , prompting a notable shift in medication trends. Obtaining these treatments remains a complex situation , with public healthcare system provision currently limited and private clinics offering prescriptions at a premium . Questions are be